Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Heron Therapeutics
HRTX
$63.8M
| $1.95M | ﹤0.01% |
61,559
+53,320
| +647% | +$1.99M |
|
2877
ESCO Technologies
ESE
$7.76B
| $1.95M | ﹤0.01% |
28,608
+18,319
| +178% | +$1.19M |
|
|
EGRX
2878
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.95M | ﹤0.01% |
28,090
+17,302
| +160% | +$1.31M |
|
|
CEQP
2879
DELISTED
Crestwood Equity Partners LP
CEQP
| $1.95M | ﹤0.01% |
52,967
-12,606
| -19% | -$461K |
|
2880
Adient
ADNT
$1.48B
| $1.95M | ﹤0.01% |
49,513
+17,635
| +55% | +$795K |
|
|
HF
2881
DELISTED
HFF Inc.
HF
| $1.95M | ﹤0.01% |
45,766
+27,446
| +150% | +$1.15M |
|
|
AXON
2882
PUT
Axon Enterprise
AXON
$48.6B
| $1.94M | ﹤0.01% |
28,400
-2,200
| -7% | -$148K |
|
2883
CALL
Kimberly-Clark
KMB
$36.5B
| $1.94M | ﹤0.01% |
17,100
-44,300
| -72% | -$4.97M |
|
2884
CALL
ATI
ATI
$31.3B
| $1.94M | ﹤0.01% |
65,700
+26,600
| +68% | +$715K |
|
2885
PUT
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
| $1.94M | ﹤0.01% |
23,000
-25,900
| -53% | -$2.22M |
|
2886
NBT Bancorp
NBTB
$2.79B
| $1.93M | ﹤0.01% |
50,374
+32,354
| +180% | +$1.29M |
|
2887
CALL
Humana
HUM
$46.1B
| $1.93M | ﹤0.01% |
5,700
-18,100
| -76% | -$5.88M |
|
2888
PUT
Qorvo
QRVO
$8.66B
| $1.93M | ﹤0.01% |
25,100
-22,600
| -47% | -$1.81M |
|
2889
Varonis Systems
VRNS
$4.95B
| $1.93M | ﹤0.01% |
79,050
-72,327
| -48% | -$1.76M |
|
2890
Chefs' Warehouse
CHEF
$4.51B
| $1.92M | ﹤0.01% |
52,905
+21,757
| +70% | +$672K |
|
2891
Enova International
ENVA
$6.51B
| $1.92M | ﹤0.01% |
66,740
+44,041
| +194% | +$1.5M |
|
2892
PUT
Ubiquiti
UI
$35B
| $1.92M | ﹤0.01% |
19,400
+17,000
| +708% | +$1.5M |
|
2893
Integra LifeSciences
IART
$1.43B
| $1.92M | ﹤0.01% |
29,106
-64,147
| -69% | -$3.99M |
|
|
FLAT
2894
DELISTED
iPath US Treasury Flattener ETN
FLAT
| $1.92M | ﹤0.01% |
+30,000
| New | +$1.91M |
|
|
ZGNX
2895
DELISTED
Zogenix, Inc.
ZGNX
| $1.92M | ﹤0.01% |
38,627
-21,867
| -36% | -$1.11M |
|
2896
PUT
Allstate
ALL
$65.2B
| $1.92M | ﹤0.01% |
19,400
-41,500
| -68% | -$4.05M |
|
2897
LendingTree
TREE
$447M
| $1.92M | ﹤0.01% |
8,327
-1,957
| -19% | -$465K |
|
2898
CALL
Targa Resources
TRGP
$57.9B
| $1.92M | ﹤0.01% |
34,000
-23,000
| -40% | -$1.23M |
|
|
LMNX
2899
DELISTED
Luminex Corp
LMNX
| $1.91M | ﹤0.01% |
63,196
+26,735
| +73% | +$802K |
|
2900
Universal Corp
UVV
$1.14B
| $1.91M | ﹤0.01% |
29,385
+6,840
| +30% | +$436K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.